U.S. Office-based Labs Market Size, Share & Trends Analysis Report By Modality (Single Specialty, Multi-Specialty), By Service (Cardiac, Endovascular Intervention, Venous), By Specialist, And Segment Forecasts, 2025 - 2033

Chapter 01 Methodology And Scope

• 1.1 Market Segmentation & Scope
• 1.2 Segment Definitions
  • 1.2.1 Estimates And Forecast Timeline
• 1.3 Research Methodology
  • 1.3.1 Information Procurement
    • 1.3.1.1 Purchased Database
  • 1.3.2 Gvr's Internal Database
    • 1.3.2.1 Secondary Sources
    • 1.3.2.2 Primary Research
• 1.4 Information Or Data Analysis
  • 1.4.1 Data Analysis Models
• 1.5 Market Formulation & Validation
• 1.6 Model Details
  • 1.6.1 Three Pillars Of Market Estimation
    • 1.6.1.1 Secondary Market Research
    • 1.6.1.2 Primary Market Intelligence
      • 1.6.1.2.1. In-Depth Interviews (Idis)
      • 1.6.1.2.2. Online Survey Program
  • 1.6.2 Market Modeling & Forecasting
    • 1.6.2.1 Procedure Volume Estimation (2021-2024)
    • 1.6.2.2 Average Cost Estimation (2021-2024)
    • 1.6.2.3 Forecasting (2025-2033)
    • 1.6.2.4 Segment Share Analysis
• 1.7 List Of Secondary Sources
• 1.8 List Of Abbreviations
• 1.9 Objectives
  • 1.9.1 Objective - 1
  • 1.9.2 Objective - 2
  • 1.9.3 Objective - 3

Chapter 02 Executive Summary

• 2.1 Market Snapshot
• 2.2 Market Segmentation
• 2.3 Market Segmentation
• 2.4 Competitive Landscape

Chapter 03 Market Variables, Trends & Scope

• 3.1 Market Lineage Outlook
  • 3.1.1 Parent Market Outlook
  • 3.1.2 Ancillary Market Outlook
• 3.2 Market Dynamics
  • 3.2.1 Market Driver Analysis
    • 3.2.1.1 Increasing Volume Of Cardiovascular And Radiological Procedures
      • 3.2.1.1.1. Case Study: Peripheral Vascular Interventions For Peripheral Artery Disease (Pad) In Office-Based Labs
    • 3.2.1.2 Growing Preference For Office-Based Labs Over Hospitals
      • 3.2.1.2.1. Case Study: Trends In Peripheral Vascular Interventions And The Rise Of Office-Based Laboratories In The U.S.
      • 3.2.1.2.2. Case Study: Utilization Patterns And Outcomes Of Pad Procedures In Office-Based Labs Versus Hospitals.
    • 3.2.1.3 Advancing Technology And Rising Preference For Minimally Invasive Procedures
  • 3.2.2 Market Restraint Analysis
    • 3.2.2.1 High Risk Option For Severe Cases
    • 3.2.2.2 High Capital Investment And Operational Costs
  • 3.2.3 Market Opportunity Analysis
    • 3.2.3.1 Strategic Partnerships And Physician Ownership
  • 3.2.4 Market Challenges Analysis
    • 3.2.4.1 Competitive Pressure From Ambulatory Surgical Centers (Ascs) And Hospital Outpatient Departments (Hopds)
• 3.3 Regulatory Framework & Reimbursement Scenario
  • 3.3.1 Regulatory Framework
  • 3.3.2 Reimbursement Scenario
• 3.4 Business Environment Analysis Tools
  • 3.4.1 Porter's Five Forces Analysis
  • 3.4.2 Pestle Analysis

Chapter 04 U.S. Office-Based Labs Market: Modality Estimates & Trend Analysis

• 4.1 U.S. Office-Based Labs Market: Modality Movement Share Analysis, 2024 & 2033
• 4.2 U.S. Office-Based Labs Market: Modality Segment Dashboard
• 4.3 U.S. Office-Based Labs Market Size & Forecast And Forecasts, By Modality (Usd Billion)
  • 4.3.1 Single Specialty Labs
    • 4.3.1.1 Single Specialty Labs Market, 2021 - 2033 (Usd Billion)
  • 4.3.2 Multi-Specialty Labs
    • 4.3.2.1 Multi-Specialty Labs Market, 2021 - 2033 (Usd Billion)
  • 4.3.3 Hybrid Labs
    • 4.3.3.1 Hybrid Labs Market, 2021 - 2033 (Usd Billion)

Chapter 05 U.S. Office-Based Labs Market: Service Estimates & Trend Analysis

• 5.1 U.S. Office-Based Labs Market: Service Movement Share Analysis, 2024 & 2033
• 5.2 U.S. Office-Based Labs Market: Service Segment Dashboard
• 5.3 U.S. Office-Based Labs Market Size & Forecast And Forecasts, By Service (Usd Billion)
  • 5.3.1 Peripheral Vascular Intervention
    • 5.3.1.1 Reimbursement Scenario
    • 5.3.1.2 Peripheral Vascular Intervention Market, 2021 - 2033 (Usd Billion)
    • 5.3.1.3 Peripheral Vascular Intervention Procedure Volume Estimates & Forecasts, 2021 - 2033 (Units)
    • 5.3.1.4 Atherectomy
      • 5.3.1.4.1 Atherectomy Market, 2021 - 2033 (Usd Billion)
      • 5.3.1.4.2 Atherectomy Procedure Volume Estimates & Forecasts, 2021 - 2033 (Units)
    • 5.3.1.5 Vascular Angioplasty
      • 5.3.1.5.1 Vascular Angioplasty Market, 2021 - 2033 (Usd Billion)
      • 5.3.1.5.2 Vascular Angioplasty Procedure Volume Estimates & Forecasts, 2021 - 2033 (Units)
    • 5.3.1.6 Stenting
      • 5.3.1.6.1 Stenting Market, 2021 - 2033 (Usd Billion)
      • 5.3.1.6.2 Stenting Procedure Volume Estimates & Forecasts, 2021 - 2033 (Units)
    • 5.3.1.7 Other Pvi
      • 5.3.1.7.1 Other Pvi Market, 2021 - 2033 (Usd Billion)
      • 5.3.1.7.2 Other Pvi Procedure Volume Estimates & Forecasts, 2021 - 2033 (Units)
  • 5.3.2 Cardiac
    • 5.3.2.1 Reimbursement Scenario
    • 5.3.2.2 Cardiac Market, 2021 - 2033 (Usd Billion)
    • 5.3.2.3 Cardiac Procedure Volume Estimates & Forecasts, 2021 - 2033 (Units)
  • 5.3.3 Interventional Radiology
    • 5.3.3.1 Reimbursement Scenario
    • 5.3.3.2 Interventional Radiology Market, 2021 - 2033 (Usd Billion)
    • 5.3.3.3 Interventional Radiology Procedure Volume Estimates & Forecasts, 2021 - 2033 (Units)
    • 5.3.3.4 Uterine Fibroid Embolization (Ufe)
      • 5.3.3.4.1 Uterine Fibroid Embolization (Ufe) Market, 2021 - 2033 (Usd Billion)
      • 5.3.3.4.2 Uterine Fibroid Embolization (Ufe) Procedure Volume Estimates & Forecasts, 2021 - 2033 (Units)
    • 5.3.3.5 Prostate Artery Embolization (Pae)
      • 5.3.3.5.1 Prostate Artery Embolization (Pae) Market, 2021 - 2033 (Usd Billion)
      • 5.3.3.5.2 Prostate Artery Embolization (Pae) Procedure Volume Estimates & Forecasts, 2021 - 2033 (Units)
    • 5.3.3.6 Y90/Oncology
      • 5.3.3.6.1 Y90/Oncology Market, 2021 - 2033 (Usd Billion)
      • 5.3.3.6.2 Y90/Oncology Procedure Volume Estimates & Forecasts, 2021 - 2033 (Units)
    • 5.3.3.7 Other Ir
      • 5.3.3.7.1 Other Ir Market, 2021 - 2033 (Usd Billion)
      • 5.3.3.7.2 Other Ir Procedure Volume Estimates & Forecasts, 2021 - 2033 (Units)
  • 5.3.4 Venous
    • 5.3.4.1 Reimbursement Scenario
    • 5.3.4.2 Venous Market, 2021 - 2033 (Usd Million)
    • 5.3.4.3 Venous Procedure Volume Estimates & Forecasts, 2021 - 2033 (Units)
    • 5.3.3.4 Rfa (Radiofrequency Ablation) And Evlt (Endovenous Laser Therapy)
      • 5.3.3.4.1 Rfa (Radiofrequency Ablation) And Evlt (Endovenous Laser Therapy) Market, 2021 - 2033 (Usd Billion)
      • 5.3.3.4.2 Urfa (Radiofrequency Ablation) And Evlt (Endovenous Laser Therapy) Procedure Volume Estimates & Forecasts, 2021 - 2033 (Units)
    • 5.3.3.5 Sclerotherapy/Glue
      • 5.3.3.5.1 Sclerotherapy/Glue Market, 2021 - 2033 (Usd Billion)
      • 5.3.3.5.2 Sclerotherapy/Glue Procedure Volume Estimates & Forecasts, 2021 - 2033 (Units)
    • 5.3.3.6 Venous Stenting
      • 5.3.3.6.1 Venous Stenting Market, 2021 - 2033 (Usd Billion)
      • 5.3.3.6.2 Venous Stenting Procedure Volume Estimates & Forecasts, 2021 - 2033 (Units)
    • 5.3.3.7 Other Deep Vein
      • 5.3.3.7.1 Other Deep Vein Market, 2021 - 2033 (Usd Billion)
      • 5.3.3.7.2 Other Deep Vein Procedure Volume Estimates & Forecasts, 2021 - 2033 (Units)
  • 5.3.5 Endovascular Interventions
    • 5.3.5.1 Reimbursement Scenario
    • 5.3.5.2 Endovascular Interventions Market, 2021 - 2033 (Usd Million)
    • 5.3.5.3 Endovascular Interventions Procedure Volume Estimates & Forecasts, 2021 - 2033 (Units)
  • 5.3.6 Others
    • 5.3.6.1 Reimbursement Scenario
    • 5.3.6.2 Other Services Market, 2021 - 2033 (Usd Million)
    • 5.3.6.3 Other Services Procedure Volume Estimates & Forecasts, 2021 - 2033 (Units)

Chapter 06 U.S. Office-Based Labs Market: Specialist Estimates & Trend Analysis

• 6.1 U.S. Office-Based Labs Market: Specialist Movement Share Analysis, 2024 & 2033
• 6.2 U.S. Office-Based Labs Market: Specialist Segment Dashboard
• 6.3 U.S. Office-Based Labs Market Size & Forecast And Forecasts, By Specialist (Usd Billion)
  • 6.3.1 Vascular Surgeons
    • 6.3.1.1 Vascular Surgeons Market, 2021 - 2033 (Usd Billion)
  • 6.3.2 Interventional Cardiologists
    • 6.3.2.1 Interventional Cardiologists Market, 2021 - 2033 (Usd Billion)
  • 6.3.3 Interventional Radiologists
    • 6.3.3.1 Interventional Radiologists Market, 2021 - 2033 (Usd Billion)
  • 6.3.4 Other Specialists
    • 6.3.4.1 Other Specialists Market, 2021 - 2033 (Usd Billion)

Chapter 07 U.S. Office-Based Labs Market: Competitive Landscape

• 7.1 Suppliers' Competition Categorization
• 7.2 Service Providers' Competition Categorization
  • 7.2.1 Company Market Position Analysis: Suppliers
  • 7.2.2 Company Market Position Analysis: Service Provider
• 7.3 Strategy Mapping
  • 7.3.1 New Launch And Approval
  • 7.3.2 Acquisition
  • 7.3.3 Partnership & Collaboration
  • 7.3.4 Others
• 7.4 Company Profiles
  • 7.3.1 Koninklijke Philips N.V.
    • 7.3.1.1 Company Overview
    • 7.3.1.2 Financial Performance
    • 7.3.1.3 Product/Service Benchmarking
    • 7.3.1.4 Strategic Initiatives
  • 7.3.2 Ge Healthcare
    • 7.3.2.1 Company Overview
    • 7.3.2.2 Financial Performance
    • 7.3.2.3 Product/Service Benchmarking
    • 7.3.2.4 Strategic Initiatives
  • 7.3.3 Siemens Healthineers Ag
    • 7.3.3.1 Company Overview
    • 7.3.3.2 Financial Performance
    • 7.3.3.3 Product/Service Benchmarking
    • 7.3.3.4 Strategic Initiatives
  • 7.3.4 Medtronic Plc
    • 7.3.4.1 Company Overview
    • 7.3.4.2 Financial Performance
    • 7.3.4.3 Product/Service Benchmarking
    • 7.3.4.4 Strategic Initiatives
  • 7.3.5 Boston Scientific Corporation
    • 7.3.5.1 Company Overview
    • 7.3.5.2 Financial Performance
    • 7.3.5.3 Product/Service Benchmarking
    • 7.3.5.4 Strategic Initiatives
  • 7.3.6 Abbott
    • 7.3.6.1 Company Overview
    • 7.3.6.2 Financial Performance
    • 7.3.6.3 Product/Service Benchmarking
    • 7.3.6.4 Strategic Initiatives
  • 7.3.7 Envision Healthcare Corporation (Kkr)
    • 7.3.7.1 Company Overview
    • 7.3.7.2 Financial Performance
    • 7.3.7.3 Product/Service Benchmarking
    • 7.3.7.4 Strategic Initiatives
  • 7.3.8 Surgical Care Affiliates (Sca)
    • 7.3.8.1 Company Overview
    • 7.3.8.2 Financial Performance
    • 7.3.8.3 Product/Service Benchmarking
    • 7.3.8.4 Strategic Initiatives
  • 7.3.9 Surgery Partners
    • 7.3.9.1 Company Overview
    • 7.3.9.2 Financial Performance
    • 7.3.9.3 Product/Service Benchmarking
    • 7.3.9.4 Strategic Initiatives
  • 7.3.10 Cardiovascular Coalition
    • 7.3.10.1 Company Overview
    • 7.3.10.2 Financial Performance
    • 7.3.10.3 Product/Service Benchmarking
    • 7.3.10.4 Strategic Initiatives
  • 7.3.11 Th Medical
    • 7.3.11.1 Company Overview
    • 7.3.11.2 Financial Performance
    • 7.3.11.3 Product/Service Benchmarking
    • 7.3.11.4 Strategic Initiatives
  • 7.3.12 Vascular Care Group
    • 7.3.12.1 Company Overview
    • 7.3.12.2 Financial Performance
    • 7.3.12.3 Product/Service Benchmarking
    • 7.3.12.4 Strategic Initiatives
  • 7.3.13 Coastal Vascular Institute
    • 7.3.13.1 Company Overview
    • 7.3.13.2 Financial Performance
    • 7.3.13.3 Product/Service Benchmarking
    • 7.3.14.4 Strategic Initiatives

List of Tables

• Table 1 List of secondary sources
• Table 2 List of abbreviations
• Table 3 Type of procedures performed in OBLs
• Table 4 Catheter Placement(s): Medicare base case coding scenarios
• Table 5 Arterial Shunting Coil Embolization (if required): Medicare base case coding scenarios
• Table 6 Hepatic Angiogram: Medicare base case coding scenarios
• Table 7 Volume Imaging Options: Medicare base case coding scenarios
• Table 8 CT Acquisition (maybe billed in conjunction with CPT 76377): Medicare base case coding scenarios
• Table 9 Mapping Options: Medicare base case coding scenarios
• Table 10 Codes applicable between mapping and treatment: Medicare base case coding scenarios
• Table 11 Catheter Placement (Phase II): Medicare base case coding scenarios
• Table 12 Hepatic Angiogram (Phase II): Medicare base case coding scenarios
• Table 13 Tumor Embolization Phase II: Medicare base case coding scenarios
• Table 14 Microspheres Administration: Authorized User Codes (AU)
• Table 15 Post Treatment Imaging (Provider Preference): Medicare base case coding scenarios
• Table 16 U.S. office-based labs market revenue estimates and forecast, by Modality, 2021 - 2033 (USD billion)
• Table 17 U.S. office-based labs market revenue estimates and forecast, by Service, 2021 - 2033 (USD billion)
• Table 18 U.S. office-based labs market revenue estimates and forecast, by Service, 2021 - 2033 (Number of Procedures)
• Table 19 U.S. Peripheral Vascular Intervention (PVI) in OBLs market revenue estimates and forecast, by Service, 2021 - 2033 (USD Million)
• Table 20 U.S. Peripheral Vascular Intervention (PVI) in OBLs market revenue estimates and forecast, by Service Type, 2021 - 2033 (Number of Procedures)
• Table 21 U.S. venous procedures in OBLs market revenue estimates and forecast, by service type, 2021 - 2033 (USD Million)
• Table 22 U.S. venous procedures in OBLs market revenue estimates and forecast, by service type, 2021 - 2033 (Number of Procedures)
• Table 23 U.S. interventional radiology in OBLs market revenue estimates and forecast, by service type, 2021 - 2033 (USD Million)
• Table 24 U.S. interventional radiology in OBLs market revenue estimates and forecast, by service type, 2021 - 2033 (Number of Procedures)
• Table 25 U.S. office-based labs market revenue estimates and forecast, by Specialist, 2021 - 2033 (USD billion)
• Table 26 Shortage of vascular surgeons by workload analysis

List of Figures

• Fig. 1 U.S. office-based labs segmentation
• Fig. 2 Market research process
• Fig. 3 Data triangulation techniques
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value chain-based sizing & forecasting
• Fig. 7 QFD modeling for market share assessment
• Fig. 8 Market formulation & validation
• Fig. 9 Research methodology framework
• Fig. 10 Secondary research framework
• Fig. 11 Secondary research framework
• Fig. 12 Market snapshot
• Fig. 13 Market segmentation
• Fig. 14 Market segmentation
• Fig. 15 Competitive landscape
• Fig. 16 U.S. office-based labs market dynamics
• Fig. 17 U.S. office-based labs market: Porter's five forces analysis
• Fig. 18 U.S. office-based labs market: PESTLE analysis
• Fig. 19 U.S. office-based labs market: Modality movement share analysis
• Fig. 20 U.S. office-based labs market: Modality segment dashboard
• Fig. 21 Single specialty labs market, 2021 - 2033 (USD Billion)
• Fig. 22 Multi-specialty labs market, 2021 - 2033 (USD Billion)
• Fig. 23 Hybrid market, 2021 - 2033 (USD Billion)
• Fig. 24 U.S. office-based labs market: Service movement share analysis
• Fig. 25 U.S. office-based labs market: Service segment dashboard
• Fig. 26 Peripheral vascular intervention market, 2021 - 2033 (USD Billion)
• Fig. 27 Peripheral vascular intervention procedure volume estimates & forecasts, 2021 - 2033 (Units)
• Fig. 28 Atherectomy market, 2021 - 2033 (USD Billion)
• Fig. 29 Atherectomy procedure volume estimates & forecasts, 2021 - 2033 (Units)
• Fig. 30 Vascular angioplasty market, 2021 - 2033 (USD Billion)
• Fig. 31 Vascular angioplasty procedure volume estimates & forecasts, 2021 - 2033 (Units)
• Fig. 32 Stenting market, 2021 - 2033 (USD Billion)
• Fig. 33 Stenting procedure volume estimates & forecasts, 2021 - 2033 (Units)
• Fig. 34 Other PVI market, 2021 - 2033 (USD Billion)
• Fig. 35 Other PVI procedure volume estimates & forecasts, 2021 - 2033 (Units)
• Fig. 36 Cardiac market, 2021 - 2033 (USD Billion)
• Fig. 37 Cardiac procedure volume estimates & forecasts, 2021 - 2033 (Units)
• Fig. 38 Interventional radiology market, 2021 - 2033 (USD Billion)
• Fig. 39 Interventional radiology procedure volume estimates & forecasts, 2021 - 2033 (Units)
• Fig. 40 Uterine Fibroid Embolization (UFE) market, 2021 - 2033 (USD Billion)
• Fig. 41 Uterine Fibroid Embolization (UFE) procedure volume estimates & forecasts, 2021 - 2033 (Units)
• Fig. 42 Prostate Artery Embolization (PAE) market, 2021 - 2033 (USD Billion)
• Fig. 43 Prostate Artery Embolization (PAE) procedure volume estimates & forecasts, 2021 - 2033 (Units)
• Fig. 44 Y90/Oncology market, 2021 - 2033 (USD Billion)
• Fig. 45 Y90/Oncology procedure volume estimates & forecasts, 2021 - 2033 (Units)
• Fig. 46 Other IR market, 2021 - 2033 (USD Billion)
• Fig. 47 Other IR procedure volume estimates & forecasts, 2021 - 2033 (Units)
• Fig. 48 Venous market, 2021 - 2033 (USD Million)
• Fig. 49 Venous procedure volume estimates & forecasts, 2021 - 2033 (Units)
• Fig. 50 RFA (Radiofrequency Ablation) and EVLT (Endovenous Laser Therapy) market, 2021 - 2033 (USD Million)
• Fig. 51 RFA (Radiofrequency Ablation) and EVLT (Endovenous Laser Therapy) procedure volume estimates & forecasts, 2021 - 2033 (Units)
• Fig. 52 Sclerotherapy/Glue market, 2021 - 2033 (USD Million)
• Fig. 53 Sclerotherapy/Glue procedure volume estimates & forecasts, 2021 - 2033 (Units)
• Fig. 54 Venous stenting market, 2021 - 2033 (USD Million)
• Fig. 55 Venous stenting procedure volume estimates & forecasts, 2021 - 2033 (Units)
• Fig. 56 Other deep vein market, 2021 - 2033 (USD Million)
• Fig. 57 Other deep vein procedure volume estimates & forecasts, 2021 - 2033 (Units)
• Fig. 58 Endovascular interventions market, 2021 - 2033 (USD Million)
• Fig. 59 Endovascular interventions procedure volume estimates & forecasts, 2021 - 2033 (Units)
• Fig. 60 Other services market, 2021 - 2033 (USD Million)
• Fig. 61 Other services procedure volume estimates & forecasts, 2021 - 2033 (Units)
• Fig. 62 U.S. office-based labs market: Specialist movement share analysis
• Fig. 63 U.S. office-based labs market: Specialist segment dashboard
• Fig. 64 Vascular surgeons market, 2021 - 2033 (USD Billion)
• Fig. 65 Interventional cardiologists market, 2021 - 2033 (USD Billion)
• Fig. 66 Interventional radiologists market, 2021 - 2033 (USD Billion)
• Fig. 67 Other specialists market, 2021 - 2033 (USD Billion)
• Fig. 68 Suppliers' competition categorization
• Fig. 69 Service providers' competition categorization
• Fig. 70 Company market position analysis: Suppliers
• Fig. 71 Company market position analysis: Service providers
• Fig. 72 Strategy mapping